Investments in the biotech, pharmaceutical and life science sectors have seen some good returns since COVID struck. While it is true that much of the initial gains have been retraced, Dr Navid Malik, a medically trained specialist who is now a life scienc

Is Covid largely over or is the biotech sector ripe for more upside?

Get exclusive insights from analysts and industry experts with IG Trading the Markets – a podcast that covers everything from forex to stock trading, helping you to get more from the financial markets.

Any opinions, news, research, analysis, prices or other information contained does not constitute investment advice.

Losses can exceed deposits, 76% of retail clients lose money.

Business

News

Investing

Business News

Get exclusive insights from analysts and industry experts with IG Trading the Markets – a podcast that covers everything from forex to stock trading, helping you to get more from the financial markets. Any opinions, news, research, analysis, prices or other information contained does not constitute investment advice. Losses can exceed deposits, 76% of retail clients lose money.

Share Is Covid largely over or is the biotech sector ripe for more upside?

Sign up to save your podcasts

Is Covid largely over or is the biotech sector ripe for more upside?

Is Covid largely over or is the biotech sector ripe for more upside?